[1]
“Use of erlotinib throughout pregnancy: a case-report of a patient with metastatic lung adenocarcinoma”., Rev. colomb. hematol. oncol. , vol. 4, no. 2, p. 51, Dec. 2017, doi: 10.51643/22562915.261.